Benzoyl nitroside (5) was generated in solution by laser photolysis of 3,5-diphenyl-1,2,4-oxadiazole-4-oxide (4) and studied by time-resolved infrared spectroscopy. The second-order rate constants for reaction of 5 with diethylamine and 1,3-cyclohexadiene were determined to be (1.3 +/- 0.5) x 10(5) M(-1) s(-1) and (6.0 +/- 0.5) x 10(3) M(-1) s(-1), respectively. The formation of nitroxyl (HNO), a product of the reaction of 5 with diethylamine, was also observed.
P-Nitrosophosphates, such as 9, react as N-O heterodienophiles with 1,3-dienes to form highly functionalized cycloadducts that can be directly transformed into allylic phosphoramidates. The in situ periodate oxidation of the unstable N-hydroxyphosphoramidate precursors provides an efficient preparation of these new reactive intermediates. P-Nitrosophosphate (9) regioselectively reacts with 1-methoxy-1,3-butadiene to provide cycloadduct 16. P-Nitrosophosphate (9) also reacts with 9,10-dimethylanthracene to give cycloadduct 17, which undergoes retro Diels-Alder dissociation to re-form 9. In the absence of a 1,3-diene, the decomposition of 17 produces nitrous oxide, evidence for nitroxyl, the one-electron-reduced form of nitric oxide. An asymmetric P-nitrosophosphate reacted with 1,3-cyclohexadiene to form a mixture of diastereomeric cycloadducts (19 and 20) in a 1.6:1 ratio. These results identify P-nitrosophosphates as new species that react similarly to acyl nitroso compounds, making them useful synthetic intermediates and potential nitroxyl delivery agents.
Hydroxyurea has emerged as a new therapy for sickle cell disease but a complete mechanistic description of its beneficial actions does not exist. Patients taking hydroxyurea show evidence for the in vivo conversion of hydroxyurea to nitric oxide (NO), which also has drawn interest as a sickle cell disease treatment. While the chemical oxidation of hydroxyurea produces NO or NO-related products, NO formation from the reactions of hydroxyurea and hemoglobin do not occur fast enough to account for the observed increases in patients taking hydroxyurea. Both horseradish peroxidase and catalase catalyze the rapid formation of nitric oxide and nitroxyl (HNO) from hydroxyurea. In these reactions, hydroxyurea is converted to an acyl nitroso species that hydrolyzes to form HNO. The ferric heme protein then oxidizes HNO to NO that combines with the heme iron to form a ferrous-NO complex that may act as an NO donor. In general, acyl nitroso compounds, regardless of the method of their preparation, hydrolyze to form HNO and the corresponding carboxylic acid derivative. Similarly, the incubation of blood and hydroxyurea with urease rapidly form NO-related species suggesting the initial urease-mediated hydrolysis of hydroxyurea to hydroxylamine, which then reacts quickly with hemoglobin to form these products. These studies present two NO releasing mechanisms from hydroxyurea that are kinetically competent with clinical observations.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.